Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Research

Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians

Stéphanie Sidorkiewicz, Viet-Thi Tran, Cécile Cousyn, Elodie Perrodeau and Philippe Ravaud
The Annals of Family Medicine September 2016, 14 (5) 415-421; DOI: https://doi.org/10.1370/afm.1965
Stéphanie Sidorkiewicz
1Department of General Medicine, Paris Descartes University, Paris, France
2METHODS Team, INSERM U1153, Epidemiology and Statistics Sorbonne Paris Cité Research Centre, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viet-Thi Tran
2METHODS Team, INSERM U1153, Epidemiology and Statistics Sorbonne Paris Cité Research Centre, France
3Department of General Medicine, Paris Diderot University, Paris, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: thi.tran-viet@htd.aphp.fr
Cécile Cousyn
3Department of General Medicine, Paris Diderot University, Paris, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elodie Perrodeau
2METHODS Team, INSERM U1153, Epidemiology and Statistics Sorbonne Paris Cité Research Centre, France
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Ravaud
2METHODS Team, INSERM U1153, Epidemiology and Statistics Sorbonne Paris Cité Research Centre, France
4French Cochrane Centre, Paris, France
5Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, New York
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Published eLetters

If you would like to comment on this article, click on Submit a Response to This article, below. We welcome your input.

Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

  • Author response to Dr Katelyn Klosterman on Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians
    Viet-Thi Tran
    Published on: 01 December 2016
  • Journal club discussion
    Katelyn Klosterman
    Published on: 17 November 2016
  • Published on: (1 December 2016)
    Page navigation anchor for Author response to Dr Katelyn Klosterman on Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians
    Author response to Dr Katelyn Klosterman on Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians
    • Viet-Thi Tran, Researcher
    • Other Contributors:

    Dear Dr Katelyn Klosterman and Colleagues,

    We thank you for giving us the opportunity to discuss some aspects of our work.

    First, we would like to clarify how we assessed medication adherence in this study. As reported in the Methods section, drug adherence was assessed using a validated self-reported adherence instrument (1). This instrument is not based on two random questions obtained from a validat...

    Show More

    Dear Dr Katelyn Klosterman and Colleagues,

    We thank you for giving us the opportunity to discuss some aspects of our work.

    First, we would like to clarify how we assessed medication adherence in this study. As reported in the Methods section, drug adherence was assessed using a validated self-reported adherence instrument (1). This instrument is not based on two random questions obtained from a validated questionnaire; instead, it is a five-item tool developed through a multistep approach: 1) theoretical conceptualization, 2) development of the tool (including review of the literature, interviews of experts and pilot testing) and 3) assessment of its measurement properties (including assessment of criterion validity, construct validity, and reliability by a test-retest method)(1). This instrument was valid and reliable to assess drug adherence for each drug taken by patients. We agree with Klosterman and Colleagues that electronic adherence measurements are more precise than self-reported questionnaires, but it is not possible, neither in practice nor in research, to assess adherence for every medication taken by patients using these methods.

    Second, Klosterman and Colleagues found our definition of adherence in this study "quite vague", stating that we failed to consider some reasons for non-adherence such as financial reasons in our classification between intentional and unintentional non-adherence. Some points should be highlighted with regards to this critique. First, this study does not seek to draw up an exhaustive list of the reasons for non-adherence but rather to highlight patient reported reasons for non-adherence for a more patient-centered perspective of our results. Second, it is no surprise that, in our study, no patient reported financial reasons for non-adherence existed. Our study was conducted in France where the National Insurance System provides free of charge care for all patients with chronic conditions. Finally, as reported in the Methods section, we used a framework developed by Gadkari and McHorney (2) to classify intentional and unintentional non-adherence. Examples were intended to help readers, and not reduce or blur the definition of intentional or unintentional non-adherence.

    Third, with regards to the recruitment of patients and physicians, we agree that the sentence we wrote could be misleading. In fact, we recruited a total of 243 patients from 6 different sites from May 2014 to August 2014. For each recruited patient, his or her primary care physician was contacted by mail. The physician response rate was 33.5%. We therefore obtained patients' assessments of drug adherence and their corresponding primary care physicians' assessments of drug importance for 498 drugs taken by 128 patients. As reported in the Methods section, physician's results were matched with their patients' results. Because we compared ratings using two different ordinal scales, concordance measurements could not be used and thus, we calculated Spearman correlation coefficients.

    Fourth, we agree that the interpretation of the word "important" may leave the meaning up for interpretation. That's why we asked primary care physicians the question of importance. Because in France, there is a "gatekeeper" system, recruited physicians were well aware of all the medications, context, conditions and care goals of patients.

    Finally, regarding the comparison between the perception of patient medication adherence by physicians and patients, we want to highlight that this comparison was not the primary objective of the study. Thus, we did not explore the factors that may have impacted physicians' perceptions of patients' adherence. Studies have analyzed these factors (3) and could supplement the results of our study.

    In conclusion, we thank Klosterman and Colleagues for their discussion. We share their analysis that limited consultation time is a pitfall to effective patient-doctor communication. Our results call for a change in the consultation model for patients with chronic conditions who are at risk of poor adherence to important treatments.

    1. Sidorkiewicz S, Tran VT, Cousyn C, Perrodeau E, Ravaud P. Development and validation of an instrument to assess treatment adherence for each individual drug taken by a patient. BMJ open. 2016;6(5):e010510.

    2. Gadkari AS, McHorney CA. Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res. 2012;12:98.

    3. Phillips LA, Leventhal EA, Leventhal H. Factors associated with the accuracy of physicians' predictions of patient adherence. Patient education and counseling. 2011;85(3):461-7.

    Competing interests: None declared

    Show Less
    Competing Interests: None declared.
  • Published on: (17 November 2016)
    Page navigation anchor for Journal club discussion
    Journal club discussion
    • Katelyn Klosterman, Medical Student
    • Other Contributors:

    The purpose of this discussion is to analyze the study discussed in the paper titled: Discordance Between Drug adherence as Reported by Patients and Drug Importance by Stephanie Sidorkiewicz, MD; Viet-Thi Tran, MD, PhD; Cecile Cousyn, MD; Elodie Perrodeau MSc; Philippe Ravand, MD, PhD. The study compares patient and physician assessment of drug adherence and of drug importance; and it compares drug adherence reported by p...

    Show More

    The purpose of this discussion is to analyze the study discussed in the paper titled: Discordance Between Drug adherence as Reported by Patients and Drug Importance by Stephanie Sidorkiewicz, MD; Viet-Thi Tran, MD, PhD; Cecile Cousyn, MD; Elodie Perrodeau MSc; Philippe Ravand, MD, PhD. The study compares patient and physician assessment of drug adherence and of drug importance; and it compares drug adherence reported by patients with drug importance as assessed by their physician. The overall goal of this study was to see if the viewpoint of physicians matches the viewpoint of their patients.

    This study recruited 128 patients from 6 different sites who were receiving at least one prescription drug that was taken on a scheduled basis for at least 30 days from both hospital and clinic settings in France. Patients with cognitive impairment or language barriers, and patients who were receiving medication from a nurse or home care provider were excluded from this study. Patients were asked to assess their drug adherence through a self-report adherence instrument that was based off of 2 random questions obtained from a validated questionnaire. Patient perceived importance of their medications was assessed using the Adherence Estimator. The Adherence Estimator predicts nonadherance associated with beliefs about medicine. Finally patients were asked open ended questions about the reasons why they do not adhere to their medication regime. Each participant's physician was contacted and given an 11-step rating scale to assess their patient's adherence to their prescribed medications. Secondly, physicians were asked to rate the importance of each drug to their patient's health on a scale of 0 (not important) to 10 (very important).

    For quantitative data, authors used interquartile ranges in order to exclude outliers from overall data. To analyze the qualitative data obtained from the response from the open-ended questions, nonadherance was defined as "a person's behavior fails to coincide with medical advice". The authors then subdivide nonadherance into two broad categories: "intentional nonadherance" or "unintentional nonadherance". "Intentional nonadherance" is defined as the patient willingly choosing not to take their prescribed medication whether it was because the patient did not think the medication was helping them or the patient did not like the side effects of the medication. "Unintentional nonadherance" is defined as patients accidentally forgetting to take their medication, or if the patient runs out of their medication. Unfortunately, the definition for adherence seems quite vague and the authors fail to consider other reasons why patients chose not to take their medication like financial reasons, and whether or not this would be defined as "intentional" or "unintentional".

    Results show that the median age of patients studied was 59.8 years, 63% of participants were female, 90% of participants were in the outpatient setting, and on average patients were taking 3 medications. In this study, the average age of the physician recruited was 57.4 years, 75% were female, and 56% were general practioners. It is unclear if the authors tried to match the physician's results with their patients results or if the data is just a sum of all patients and all doctors that could be recruited.

    Initial analysis takes a closer look at whether there is a correlation of patient and physician assessment of drug importance. There was a very weak correlation between patient and physician evaluation of drug importance. This weak correlation shows that what the patient thinks is important is not what the physician thinks is important and vice versa. Therefore it can be concluded that there is lack of patient-centered communication, and this discrepancy can be improved if discussion was encouraged between patient and physician. In addition, these results show that physicians or other healthcare professionals may need to take more time to educate patients about their health conditions in order to positively affect the overall health of their patients. Other results find that physicians rated 13% of the medication that patients were taking as less important for the patient's health although these drugs were prescribed. Many of these drugs labeled, as "less important" were medications used for psychiatry, which shows that many physicians in this study neglect to see the importance of mental health issues. In addition, a key limitation in this study is that the authors do not define what "important" means and leave the meaning up for interpretation. For instance, does important refer to the benefit the medication does to a patient's physical health or to their quality of life? For example, is it more important for a 90 year old patient to take 20 medications to decrease their mortality risk or should the patient be on less medications and enjoy their quality of life. These are important conversations doctors always need to have with their patients, and doctors always need to assess what matters most to the patient. Finally the other drugs that are listed as "not important" raises the issue of polypharmacy and if doctors are prescribing medications just to prescribe medications for a "quick fix".

    In addition, the study examined both patient and physician assessment of drug adherence, and the correlation between these assessments was also weak. Many things can impact how a physician perceives their patients adhere to their medications. Unfortunately the article fails to analyze any of these factors.

    Finally, the study compares patient reported drug adherence to physician assessed drug importance. Unfortunately, 20% of the medications that patient report poor adherence were assessed as important by their physician. This poor adherence included antihypertensive medications, platelet aggregation inhibitors, and other cardiac agents, oral blood glucose lowering drugs and insulin. These results show that patients do not understand the importance of their chronic disease, and how their chronic disease can impact their body. For instance, patients may not understand that their high blood pressure is consistently affecting their kidneys and peripheral vessels every second because they do feel the side effects until several years have passed. In addition, these patients may not realize that these antihypertensive medications are protecting their peripheral vessels and kidney from damage because they do not feel or sense or see the impact it is having on their body. These misunderstanding need to be addressed by healthcare professionals, and points to the importance of patient education.

    Overall, this study shows that there is no correlation between patient and physician assessment of drug importance and drug adherence, and no correlation between patients reported drug adherence and physician assessed drug importance. This study shows that there is a lack of communication between the patient and doctor, and this issue needs to be addressed. To address this issue some barriers need to be discussed. The most important barrier is: time. Physicians are pushed to see patients in 15-minute appointments. Physicians already struggle to obtain a patient's history, perform a physical exam, and diagnose in fifteen minutes. Since it is unlikely for physicians to have more time with their patients due to their heavy patient load, this poses the importance of using midlevel providers to help in the process of educating patients about their diagnosis and the importance of their medications.

    There are several limitations to this study. First of all the sample size was only limited to 128 patients and the physician response rate was only 33.5%. In addition, the patients in this study were not wholly representative of those on long-term drug therapy because they were recruited in only 6 different centers in France. The authors assume that 2 random parts of a whole validated questionnaire makes their 2-question instrument valid, but this is not the case. In addition, most data that is obtained through self-report has the potential to be biased. The study does not point out the differences in the sites or how much education the patients were receiving at each specific site. Though the average time the physician spent with their patients was given to the reader, there is no breakdown of how this time was spent with the patient. Finally 40% of the physicians in this study were trained before 1985, and this study does not account for any generational value differences.

    In the end, the only way to lessen this discordance between patient adherence to medications and physician perceived importance is to use a multidisciplinary team to provide patient centered care. This patient centered care should focus on making the patient feel comfortable through positive body language and support from their doctor and midlevel providers, and it should allow patients to ask questions about their conditions and medications, and provide patients with the education they need to take control of their health.

    Competing interests: None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 14 (5)
The Annals of Family Medicine: 14 (5)
Vol. 14, Issue 5
September/October 2016
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
15 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians
Stéphanie Sidorkiewicz, Viet-Thi Tran, Cécile Cousyn, Elodie Perrodeau, Philippe Ravaud
The Annals of Family Medicine Sep 2016, 14 (5) 415-421; DOI: 10.1370/afm.1965

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians
Stéphanie Sidorkiewicz, Viet-Thi Tran, Cécile Cousyn, Elodie Perrodeau, Philippe Ravaud
The Annals of Family Medicine Sep 2016, 14 (5) 415-421; DOI: 10.1370/afm.1965
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Viewpoint: defining adherence phenotype and endotypes to personalise asthma management
  • Treatment burden and ability to work
  • Patients perspectives on how to decrease the burden of treatment: a qualitative study of HIV care in sub-Saharan Africa
  • Barriers and facilitators to medication adherence: a qualitative study with general practitioners
  • Informing a Different Conversation About Medication
  • In This Issue: Different Paths to Discovery
  • Google Scholar

More in this TOC Section

  • Performance-Based Reimbursement, Illegitimate Tasks, Moral Distress, and Quality Care in Primary Care: A Mediation Model of Longitudinal Data
  • Adverse Outcomes Associated With Inhaled Corticosteroid Use in Individuals With Chronic Obstructive Pulmonary Disease
  • Family-Based Interventions to Promote Weight Management in Adults: Results From a Cluster Randomized Controlled Trial in India
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Chronic illness
  • Methods:
    • Quantitative methods
  • Other research types:
    • Health services
  • Core values of primary care:
    • Personalized care
  • Other topics:
    • Communication / decision making

Keywords

  • medication adherence
  • drug therapy
  • physician-patient relation
  • drug prescription
  • practice-based research
  • primary care

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine